Welcoming New TB-CRE
Postdoctoral Fellows
Posted on: Friday 16th October, 2026

The TB-CRE is pleased to welcome two outstanding postdoctoral fellows, Dr Jodie Schildkraut and Dr James Trauer, whose expertise will strengthen our research programs across tuberculosis clinical trials, modelling and global TB control.

Dr Jodie Schildkraut is a postdoctoral fellow at the University of Sydney's NHMRC Clinical Trials Centre and also holds a postdoctoral position at Radboud University Medical Center in the Netherlands. Her research focuses on TB treatment trials, from Phase 2 through to Phase 3 studies, including both novel drug candidates and optimised treatment regimens. Jodie plays a leading role in international collaborations such as UNITE4TB and PanACEA, and serves on the steering committee for the FAST-TB Knowledge Integration for TB Treatment Development initiative. She is also particularly interested in developing biomarkers as novel clinical trial endpoints to improve the efficiency of TB research.

Dr James Trauer brings expertise in tuberculosis epidemiology, mathematical modelling and public health. A respiratory, sleep, general and public health physician, James has worked in TB and mycobacterial disease control across the Northern Territory, the Royal Melbourne Hospital and The Alfred. His research focuses on building the next generation of mechanistic TB models for high-burden settings, drawing on data science, Bayesian inference and simulation modelling. He is currently working to integrate TB modelling with macroeconomic simulations to better understand the broader health and economic impacts of tuberculosis.
We warmly welcome Jodie and James to the TB-CRE and look forward to the valuable contributions they will make to advancing TB research and improving outcomes for people affected by tuberculosis worldwide.
